165
Views
0
CrossRef citations to date
0
Altmetric
RESEARCH LETTER

The Effect of Biologic Therapy in Severe Asthmatics and ER Admissions During COVID-19: A Retrospective Study

, , ORCID Icon, ORCID Icon, , & ORCID Icon show all
Pages 833-837 | Received 20 Apr 2023, Accepted 27 Jul 2023, Published online: 10 Aug 2023

References

  • Reddel HK, Bacharier LB, Bateman ED, et al. Global initiative for asthma strategy 2021: executive summary and rationale for key changes. Am J Respir Crit Care Med. 2022;205(1):17–35. doi:10.1164/rccm.202109-2205PP
  • Sinha P, Matthay MA, Calfee CS. Is a “Cytokine Storm” Relevant to COVID-19? JAMA Intern Med. 2020;180(9):1152–1154. doi:10.1001/jamainternmed.2020.3313
  • Arias M, Oliveros H, Lechtig S, Bustos RH. Biologics in COVID-19 so far: systematic review. Pharmaceuticals. 2022;15(7):783. doi:10.3390/ph15070783
  • Heffler E, Detoraki A, Contoli M, et al. COVID‐19 in Severe Asthma Network in Italy (SANI) patients: clinical features, impact of comorbidities and treatments. Allergy. 2021;76(3):887–892. doi:10.1111/all.14532
  • Donlan AN, Mallawaarachchi I, Sasson JM, Preissner R, Loomba JJ. Dupilumab use is associated with protection from coronavirus disease 2019 mortality: a retrospective analysis. Clin Infect Dis. 2023;76(1):148–151. doi:10.1093/cid/ciac745
  • Sasson J, Donlan AN, Ma JZ, et al. Safety and efficacy of dupilumab for the treatment of hospitalized patients with moderate to severe coronavirus disease 2019: a phase 2a trial. Open Forum Infect Dis. 2022;9(8):ofac343. doi:10.1093/ofid/ofac343
  • Yan B, Yang J, Xie Y, Tang X. Relationship between blood eosinophil levels and COVID-19 mortality. World Allergy Org J. 2021;14(3):100521. doi:10.1016/j.waojou.2021.100521
  • Akenroye A, Lassiter G, Jackson J, et al. Effectiveness of mepolizumab, benralizumab, and dupilumab in eosinophilic asthma: a Bayesian network meta-analysis. J Allergy Clin Immunol. 2022;149(2):AB147. doi:10.1016/j.jaci.2021.12.496
  • Jackson DJ, Busse WW, Bacharier LB, et al. Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2. J Allergy Clin Immunol. 2020;146(1):203–206.e3. doi:10.1016/j.jaci.2020.04.009
  • Cruz R, Diz-de Almeida S, López de Heredia M, et al. Novel genes and sex differences in COVID-19 severity. Hum Mol Genet. 2022;31(22):3789–3806. doi:10.1093/hmg/ddac132
  • Kalidhindi RSR, Borkar NA, Ambhore NS, Pabelick CM, Prakash YS, Sathish V. Sex steroids skew ACE2 expression in human airway: a contributing factor to sex differences in COVID-19? Am J Physiol Lung Cell Mol Physiol. 2020;319(5):L843–7. doi:10.1152/ajplung.00391.2020
  • Takahashi T, Ellingson MK, Wong P, et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature. 2020;588(7837):315–320. doi:10.1038/s41586-020-2700-3